Invasight
Z├╝rich
About Invasight
Invasight is a clinical biotech company that focused on revolutionizing cell invasion research. The company was founded in 2019 and is headquartered in Zurich, Switzerland.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.7M
- Funding stage: Seed
- Last round: Seed (Jun 2022)
- Website: invasight.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/invasight-139057 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.